| P50 | author | Harry Malech | Q42654598 |
| P2093 | author name string | Elizabeth M Kang | |
| | Kyu Lee Han | |
| | Seung-Kwon Ha | |
| | Cattlena M Changpriroa | |
| | Sherry M Koontz | |
| | Stephenie V M Thomas | |
| P2860 | cites work | Foxp3 programs the development and function of CD4+CD25+ regulatory T cells | Q27860714 |
| | Adenosine A2A receptor agonists as anti-inflammatory agents | Q28242079 |
| | Adenosine A2A agonists in development for the treatment of inflammation | Q28261970 |
| | Adenosine inhibits activation-induced T cell expression of CD2 and CD28 co-stimulatory molecules: role of interleukin-2 and cyclic AMP signaling pathways | Q28511859 |
| | Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression | Q29615344 |
| | An essential role for Scurfin in CD4+CD25+ T regulatory cells | Q29618395 |
| | A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4+ T cells | Q30435569 |
| | Adenosine in tissue protection and tissue regeneration | Q30435890 |
| | Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease | Q30437360 |
| | Adenosine A2A receptor activation attenuates inflammation and injury in diabetic nephropathy | Q30438880 |
| | Suppression of inflammatory and immune responses by the A(2A) adenosine receptor: an introduction | Q30440124 |
| | A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells. | Q30440525 |
| | Cutting edge: Critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis | Q30441350 |
| | Adenosine A2A receptor activation reduces hepatic ischemia reperfusion injury by inhibiting CD1d-dependent NKT cell activation | Q30442067 |
| | Adenosine A2A receptor activation limits graft-versus-host disease after allogenic hematopoietic stem cell transplantation | Q33615249 |
| | Current and future approaches for control of graft-versus-host disease | Q33642625 |
| | Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics | Q34144161 |
| | A Crucial Role for Host APCs in the Induction of Donor CD4+CD25+ Regulatory T Cell-Mediated Suppression of Experimental Graft-versus-Host Disease | Q34312261 |
| | CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease | Q34525987 |
| | Adoptive transfer of T-cell precursors enhances T-cell reconstitution after allogeneic hematopoietic stem cell transplantation | Q34561047 |
| | Suppression of inflammation by low-dose methotrexate is mediated by adenosine A2A receptor but not A3 receptor activation in thioglycollate-induced peritonitis. | Q34896844 |
| | Cytokines, viruses, and graft-versus-host disease | Q34977543 |
| | Pathophysiology of acute graft-versus-host disease | Q35634710 |
| | Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease | Q35848458 |
| | Deficiency of CD73/ecto-5'-nucleotidase in mice enhances acute graft-versus-host disease | Q35995245 |
| | Alterations in the adenosine metabolism and CD39/CD73 adenosinergic machinery cause loss of Treg cell function and autoimmunity in ADA-deficient SCID | Q36185196 |
| | Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation | Q36370863 |
| | Adenosine A2A receptor antagonists: blockade of adenosinergic effects and T regulatory cells | Q36496998 |
| | T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR. | Q36693820 |
| | Novel mechanism of rapamycin in GVHD: increase in interstitial regulatory T cells | Q36831117 |
| | Treatment options in steroid-refractory acute graft-versus-host disease following hematopoietic stem cell transplantation | Q36904078 |
| | Impact of immunosuppressive drugs on CD4+CD25+FOXP3+ regulatory T cells: does in vitro evidence translate to the clinical setting? | Q37116728 |
| | Donor reactive regulatory T cells | Q37485835 |
| | Adenosine receptors and inflammation | Q37565170 |
| | Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5'-nucleotidase-mediated conversion of adenine nucleotides | Q39797150 |
| | Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production | Q41908710 |
| | Efficient and selective prevention of GVHD by antigen-specific induced Tregs via linked-suppression in mice | Q42109680 |
| | CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation | Q44408941 |
| | Immune reconstitution is preserved in hematopoietic stem cell transplantation coadministered with regulatory T cells for GVHD prevention | Q44641693 |
| | Graft-versus-host disease prevention by rapamycin: cellular mechanisms | Q46600793 |
| | Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection. | Q53072852 |
| | Regulatory T-cells in the graft and the risk of acute graft-versus-host disease after allogeneic stem cell transplantation. | Q53557826 |
| | Elevation of intracellular cyclic AMP in alloreactive CD4(+) T Cells induces alloantigen-specific tolerance that can prevent GVHD lethality in vivo. | Q53558142 |
| | Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue | Q61762159 |
| | The antiinflammatory effects of an adenosine kinase inhibitor are mediated by adenosine | Q72028809 |
| | Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat ad | Q73574475 |
| | The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality | Q78033315 |
| | Gastrointestinal involvement in chronic graft-versus-host disease: a clinicopathologic study | Q78812754 |
| | Rapamycin, not cyclosporine, permits thymic generation and peripheral preservation of CD4+ CD25+ FoxP3+ T cells | Q79919091 |
| | Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma | Q80135176 |
| | The use of laparoscopic liver biopsies in pediatric patients with hepatic dysfunction following allogeneic hematopoietic stem cell transplantation | Q81261229 |
| | Can Treg therapy prevent GVHD? | Q83253234 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 458-468 | |
| P577 | publication date | 2012-12-07 | |
| P1433 | published in | Journal of Immunology | Q3521441 |
| P1476 | title | Adenosine A₂A receptor agonist-mediated increase in donor-derived regulatory T cells suppresses development of graft-versus-host disease | |
| P478 | volume | 190 | |